SHL to speak at the upcoming Drug Delivery Trends symposium in Korea
pharmafile | September 28, 2011 | Feature | Manufacturing and Production | auto injector, autoinjector, drugy delivery, pharmapack
SHL Marketing Director Steven Kaufman will be speaking at the upcoming Primary Packaging and Drug Delivery Trends for Injectables symposium held by Pharmapack Symposium in Seoul, Korea on Oct 14th 2011.
Whether it’s about primary/secondary packaging or delivery methods for injectables (e.g. auto injector, safety syringes, pre-filled syringes, etc), the advancement of the drug delivery technologies now available continues to stimulate discussions amongst various industry experts around the globe, including Asia. This upcoming symposium is such an example.
As one of the invited speakers, SHL Marketing Director Steven Kaufman states, “Drug delivery trends for injectables is a topic that requires close attention from not only biopharmaceutical companies that produce the injectables but also from drug delivery device manufacturers such as SHL. It’s an honor to be invited to speak at such an event so that we can share our experiences with regards to auto injectors, hear the point-of-view of other related industry experts, and of course, make time to speak face-to-face with potential clients from the region.”
SHL will also have an information display table at the symposium that will highlight some of SHL’s latest devices and related company information. For more information about the symposium please visit HERE.
About SHL
SHL is the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices. We have over 1,600 staff globally (1000 staff in Taiwan), with our primary design centers located in the USA and Sweden and manufacturing centers located in Asia.
SHL supplies auto injectors, pen injectors and inhaler systems to global pharmaceutical and biotech companies. Significant investment in R&D has enhanced our broad pipeline of “next generation” drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.
Our organization consists of three distinct group companies:
SHL Medical
Designs, develops and manufactures advanced drug delivery devices for leading pharmaceutical and biotech companies
SHL Healthcare
Develops and manufactures equipment solutions for home, hospital and long term care use
SHL Technologies
Provides contract manufacturing and engineering services for the production of complex medtech and industrial products
For additional information visit www.shl-group.com or contact us at info@shl-group.com
SHL Media Contact
Steven R. Kaufman
Marketing Director
+886 932 111 460
pr@shl-group.com
Related Content
Novartis secures US rights to Adamis’ epinephrine auto injector
Novartis has penned an agreement with Adamis Pharmaceuticals to commercialise and distribute the latter’s epinephrine …
FDA unveils guidelines to help generic medical device versions reach the market
The scandal surrounding Mylan’s price-hiking of its flagship EpiPen epinephrine auto-injector was the news of …
SHL brings innovation to Pharmapack Europe 2017
As a forward-looking company with extensive knowledge and experience, SHL delivers solutions for today on …
